Physician
Alzohaili Medical Consultants MD PC
Alzohaili Medical Consultants MD PC was paid $13.36M by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoALZOHAILI MEDICAL CONSULTANTS MD PC
DEARBORN, MI 48126
DEARBORN, MI 48126
33aNPI1689979569assigned 01/24/2011
33bProvider typeEndocrinology, Diabetes & Metabolism Physician
28Total paid$13.36M
24GClaims548,997
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Endocrinology, Diabetes & Metabolism Physician providers in Michigan
Rank by total paid#1 of 37
Median peer was paid$136K
This provider vs. median98×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,570 | $1.09M | |
| 2019 | 63,518 | $1.30M | |
| 2020 | 59,774 | $1.44M | |
| 2021 | 88,431 | $2.02M | |
| 2022 | 103,454 | $2.52M | |
| 2023 | 106,501 | $2.75M | |
| 2024incomplete | 81,749 | $2.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 81,246 | 74,984 | $5.47M |
| 99490 | Ccm add 20min | 12% | 50,594 | 50,394 | $1.56M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.7% | 12,544 | 12,435 | $1.17M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.0% | 19,519 | 18,163 | $941K |
| 76536 | 5.8% | 11,977 | 11,915 | $776K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.2% | 6,327 | 6,001 | $560K |
| 95250 | 3.4% | 5,436 | 5,404 | $448K | |
| 99439 | 2.3% | 10,051 | 10,018 | $306K | |
| 92250 | 1.1% | 7,575 | 7,322 | $152K | |
| 95251 | 1.1% | 7,834 | 7,633 | $150K | |
| 99205 | Prolong outpt/office vis | <1% | 1,151 | 1,150 | $131K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,701 | 1,664 | $122K |
105 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,960 | $121K |
| 82947 | <1% | 32,245 | $101K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,243 | $89K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,605 | $86K |
| 99457 | <1% | 3,132 | $86K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,627 | $80K |
| V2020 | Frames, purchases | <1% | 4,031 | $80K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,318 | $75K |
| 10005 | <1% | 909 | $71K | |
| 97802 | <1% | 2,852 | $59K | |
| 60100 | <1% | 712 | $49K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 2,869 | $48K |
| 99442 | <1% | 888 | $47K | |
| 92015 | Determination of refractive state | <1% | 4,833 | $47K |
| 99458 | <1% | 1,361 | $41K | |
| 99454 | <1% | 1,411 | $40K | |
| 11721 | <1% | 1,739 | $40K | |
| 93923 | <1% | 611 | $37K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 786 | $36K |
| 99441 | <1% | 896 | $29K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 373 | $22K |
| 76942 | <1% | 673 | $21K | |
| 11056 | <1% | 464 | $20K | |
| 92083 | <1% | 623 | $20K | |
| 73630 | <1% | 934 | $19K | |
| 92342 | <1% | 855 | $18K | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 3,436 | $15K |
| 92134 | <1% | 723 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,386 | $10K |
| 99223 | Prolong inpt eval add15 m | <1% | 97 | $10K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 5,836 | $9K |
| V2101 | Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens | <1% | 714 | $8K |
| 92133 | <1% | 421 | $7K | |
| 93922 | <1% | 148 | $7K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 989 | $7K |
| 95249 | <1% | 195 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 405 | $7K |
| 97803 | <1% | 102 | $6K | |
| 92285 | <1% | 609 | $6K | |
| 92132 | <1% | 437 | $6K | |
| V2102 | Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens | <1% | 403 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 135 | $5K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 139 | $5K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 802 | $5K |
| 92341 | <1% | 288 | $5K | |
| V2302 | Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens | <1% | 273 | $5K |
| 99415 | Prolong outpt/office vis | <1% | 541 | $4K |
| 17110 | <1% | 65 | $4K | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 154 | $4K |
| 77080 | <1% | 179 | $4K | |
| 99443 | <1% | 44 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 157 | $3K |
| V2301 | Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens | <1% | 177 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 116 | $3K |
| 99453 | <1% | 183 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 430 | $2K |
| 92060 | <1% | 55 | $2K | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 447 | $1K |
| 92020 | <1% | 122 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 24 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 27 | $1K |
| 99000 | <1% | 450 | $1K | |
| 99416 | Prolong outpt/office vis | <1% | 284 | $1K |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 239 | $1K |
| V2202 | Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens | <1% | 85 | $1K |
| V2300 | Sphere, trifocal, plano to plus or minus 4.00d, per lens | <1% | 108 | $952.07 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 42 | $595.98 |
| 90756 | <1% | 28 | $592.54 | |
| S0620 | Routine ophthalmological examination including refraction; new patient | <1% | 46 | $520.99 |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | <1% | 85 | $455.34 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 46 | $366.28 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 15 | $355.20 |
| 90688 | <1% | 14 | $267.05 | |
| 76514 | <1% | 43 | $253.87 | |
| 90686 | <1% | 13 | $228.36 | |
| V2303 | Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens | <1% | 14 | $199.71 |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 21 | $51.90 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 34 | $34.24 |
| 99051 | <1% | 39 | $25.00 | |
| 36000 | <1% | 594 | $15.06 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 26 | $13.18 |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 41 | $6.00 |
| 3077F | <1% | 9,117 | $0.01 | |
| 3078F | <1% | 63,980 | $0.01 | |
| 3074F | <1% | 75,303 | $0.01 | |
| 3080F | <1% | 5,617 | $0.01 | |
| 3051F | 0% | 1,678 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 929 | $0.00 |
| 3046F | 0% | 2,525 | $0.00 | |
| 3045F | 0% | 1,037 | $0.00 | |
| 2024F | 0% | 6,560 | $0.00 | |
| 2028F | 0% | 895 | $0.00 | |
| 80428 | 0% | 31 | $0.00 | |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | 0% | 150 | $0.00 |
| 2022F | 0% | 47 | $0.00 | |
| 80434 | 0% | 14 | $0.00 | |
| 3052F | 0% | 1,203 | $0.00 | |
| 3079F | 0% | 29,304 | $0.00 | |
| 3044F | 0% | 3,656 | $0.00 | |
| 3075F | 0% | 14,489 | $0.00 | |
| G8410 | Footwear evaluation performed and documented | 0% | 929 | $0.00 |
| 3072F | 0% | 331 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 266 | $0.00 |
| 80435 | 0% | 156 | $0.00 | |
| 99070 | 0% | 349 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOERIN, RAE (OFFICE MANAGER)